BLM and breast cancer: Whereas biallelic impairment is considered mandatory for the full spectrum of the syndromes to develop, WRN and BLM have additionally been suggested as BC susceptibility genes in a monoallelic setting [67–69], and dominant-negative effects or gain-of-function processes have previously been proposed for specific missense mutant WRN or BLM proteins [70].